Department of Pediatrics, Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206, USA.
J Am Board Fam Med. 2010 Mar-Apr;23(2):159-65. doi: 10.3122/jabfm.2010.02.090112.
This study was conducted to test the effectiveness of a theory-based interactive voice response (IVR) intervention to improve adherence to controller medications among adults with asthma.
Fifty participants aged 18 to 65 years who had a physician diagnosis of asthma and a prescription for a daily inhaled corticosteroid, attended a baseline visit and a final visit 10 weeks later. Participants randomized to the intervention group received 2 automated IVR telephone calls separated by one month, with one additional call if they reported recent symptoms of poorly controlled disease or failure to fill a prescription. Calls were completed in less than 5 minutes and included content designed to inquire about asthma symptoms, deliver core educational messages, encourage refilling of inhaled corticosteroid prescriptions, and increase communication with providers. Adherence was tracked during 10 weeks, with objective measures that included either electronic monitors or calculation of canister weight. Participants completed the Asthma Quality of Life Questionnaire, the Asthma Control Test, and the Beliefs in Medications Questionnaire (BMQ) during both visits.
Adherence was 32% higher among patients in the IVR group than those in the control group (P = .003). A more favorable shift in perception of inhaled corticosteroids was seen on BMQ scores of patients in the IVR group (P = .003), which in turn correlated with degree of adherence change (r = 0.342; P = .0152). No differences emerged for the Asthma Quality of Life Questionnaire or Asthma Control Test.
The IVR intervention resulted in a significant increase in adherence to inhaled corticosteroid treatment and improved BMQ scores during the study interval. The association of increased adherence with increased BMQ scores suggests that the intervention succeeded in helping participants adopt a more favorable perception of their controller medication, leading in turn to improved adherence.
本研究旨在检验基于理论的交互式语音应答(IVR)干预措施在提高哮喘成人对控制器药物的依从性方面的有效性。
50 名年龄在 18 至 65 岁之间的参与者,经医生诊断患有哮喘,开有每日吸入皮质类固醇的处方,参加了基线访问和 10 周后的最终访问。随机分配到干预组的参与者接受了 2 次自动 IVR 电话访问,间隔一个月,如果他们报告最近有疾病控制不佳或未开处方的症状,则额外打 1 次电话。电话通话不到 5 分钟,内容包括询问哮喘症状、提供核心教育信息、鼓励重新开吸入皮质类固醇处方以及增加与提供者的沟通。在 10 周内跟踪依从性,使用电子监测或计算罐重等客观措施。参与者在两次就诊时完成了哮喘生活质量问卷、哮喘控制测试和药物信念问卷(BMQ)。
IVR 组患者的依从性比对照组高 32%(P=0.003)。IVR 组患者的 BMQ 评分显示,对吸入皮质类固醇的看法发生了更有利的转变(P=0.003),这与依从性变化程度相关(r=0.342;P=0.0152)。哮喘生活质量问卷和哮喘控制测试没有差异。
IVR 干预措施显著提高了吸入皮质类固醇治疗的依从性,并在研究期间改善了 BMQ 评分。依从性增加与 BMQ 评分增加的相关性表明,干预措施成功地帮助参与者对其控制器药物产生了更有利的看法,从而提高了依从性。